{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T21:49:36Z","timestamp":1793483376354,"version":"4.5.0"},"reference-count":122,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT 2019-01837"],"award-info":[{"award-number":["PICT 2019-01837"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT 2018-3287"],"award-info":[{"award-number":["PICT 2018-3287"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","award":["PIP 2020-0386"],"award-info":[{"award-number":["PIP 2020-0386"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.bcp.2024.116555","type":"journal-article","created":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T19:34:45Z","timestamp":1727292885000},"page":"116555","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"P1","title":["Role of the RNA binding protein IGF2BP1 in cancer multidrug resistance"],"prefix":"10.1016","volume":"230","author":[{"given":"Aldana Magal\u00ed","family":"Gola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Bucci-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"Rigalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Paula","family":"Ceballos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Laura","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2024.116555_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40364-022-00441-w","article-title":"Oncofetal protein IGF2BPs in human cancer: functions, mechanisms and therapeutic potential","volume":"11","author":"Zhu","year":"2023","journal-title":"Biomark. Res."},{"key":"10.1016\/j.bcp.2024.116555_b0010","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1128\/MCB.19.2.1262","article-title":"A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development","volume":"19","author":"Nielsen","year":"1999","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2024.116555_b0015","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1007\/s00018-012-1186-z","article-title":"Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?","volume":"70","author":"Bell","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bcp.2024.116555_b0020","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1101\/gad.6.4.642","article-title":"Control of c-myc mRNA half-life in vitro by a protein capable of binding to a coding region stability determinant","volume":"6","author":"Bernstein","year":"1992","journal-title":"Genes Dev."},{"key":"10.1016\/j.bcp.2024.116555_b0025","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1128\/MCB.17.4.2158","article-title":"Characterization of a \u03b2-actin mRNA zipcode-binding protein","volume":"17","author":"Ross","year":"1997","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2024.116555_b0030","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.semcancer.2022.05.009","article-title":"The IGF2BP family of RNA binding proteins links epitranscriptomics to cancer","volume":"86","author":"Ramesh-Kumar","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bcp.2024.116555_b0035","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1083\/jcb.200206003","article-title":"Two ZBP1 KH domains facilitate \u03b2-actin mRNA localization, granule formation, and cytoskeletal attachment","volume":"160","author":"Farina","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bcp.2024.116555_b0040","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1523\/JNEUROSCI.23-08-03251.2003","article-title":"Activity-dependent trafficking and dynamic localization of zipcode binding protein 1 and \u03b2-actin mRNA in dendrites and spines of hippocampal neurons","volume":"23","author":"Tiruchinapalli","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2024.116555_b0045","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1515\/hsz-2013-0111","article-title":"Subcellular localization and RNP formation of IGF2BPs (IGF2 mRNA-binding proteins) is modulated by distinct RNA-binding domains","volume":"394","author":"W\u00e4chter","year":"2013","journal-title":"Bchm"},{"key":"10.1016\/j.bcp.2024.116555_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-018-0628-y","article-title":"Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) in cancer","volume":"11","author":"Huang","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bcp.2024.116555_b0055","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1093\/nar\/gkh754","article-title":"Sequential dimerization of human zipcode-binding protein IMP1 on RNA: a cooperative mechanism providing RNP stability","volume":"32","author":"Nielsen","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcp.2024.116555_b0060","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a032813","article-title":"Stress granules and processing bodies in translational control","volume":"11","author":"Ivanov","year":"2019","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.bcp.2024.116555_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.00924","article-title":"A network of heterochronic genes including Imp1 regulates temporal changes in stem cell properties","volume":"2","author":"Nishino","year":"2013","journal-title":"Elife"},{"key":"10.1016\/j.bcp.2024.116555_b0070","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1242\/jcs.115.10.2087","article-title":"Cytoplasmic trafficking of IGF-II mRNA-binding protein by conserved KH domains","volume":"115","author":"Nielsen","year":"2002","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bcp.2024.116555_b0075","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1128\/MCB.24.10.4448-4464.2004","article-title":"Dwarfism and impaired gut development in insulin-like growth factor II mRNA-binding protein 1-deficient mice","volume":"24","author":"Hansen","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2024.116555_b0080","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1242\/jcs.115204","article-title":"Involvement of the mRNA binding protein CRD-BP in the regulation of metastatic melanoma cell proliferation and invasion by hypoxia","volume":"125","author":"Craig","year":"2012","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bcp.2024.116555_b0085","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1242\/jcs.045278","article-title":"Blocking \u03b2-catenin binding to the ZBP1 promoter represses ZBP1 expression, leading to increased proliferation and migration of metastatic breast-cancer cells","volume":"122","author":"Gu","year":"2009","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bcp.2024.116555_b0090","first-page":"1074","article-title":"Transcriptional Regulation of CRD-BP by c-myc: implications for c-myc Functions, Genes","volume":"1","author":"Noubissi","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.bcp.2024.116555_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/HC9.0000000000000256","article-title":"In vivo CRISPR screen identifies LTN1 as a novel tumor suppressor ubiquitinating insulin\u2013like growth factor 2 mRNA\u2013binding protein 1 in hepatocellular carcinoma","volume":"7","author":"Peng","year":"2023","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.bcp.2024.116555_b0100","doi-asserted-by":"crossref","first-page":"490","DOI":"10.62347\/UYQH7683","article-title":"Anillin contributes to prostate cancer progression through the regulation of IGF2BP1 to promote c-Myc and MAPK signaling","volume":"14","author":"Liu","year":"2024","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.bcp.2024.116555_b0105","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.cell.2009.06.016","article-title":"Widespread shortening of 3\u2032UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells","volume":"138","author":"Mayr","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2024.116555_b0110","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/carcin\/bgy153","article-title":"IMP1 3\u2032 UTR shortening enhances metastatic burden in colorectal cancer","volume":"40","author":"Andres","year":"2019","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2024.116555_b0115","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1093\/nar\/gkh754","article-title":"Sequential dimerization of human zipcode-binding protein IMP1 on RNA: a cooperative mechanism providing RNP stability","volume":"32","author":"Nielsen","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcp.2024.116555_b0120","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12943-019-1109-9","article-title":"Functions of N6-methyladenosine and its role in cancer","volume":"18","author":"He","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bcp.2024.116555_b0125","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.gendis.2023.06.017","article-title":"IGF2BPs as novel m6A readers: diverse roles in regulating cancer cell biological functions, hypoxia adaptation, metabolism, and immunosuppressive tumor microenvironment","volume":"11","author":"Duan","year":"2023","journal-title":"Genes Dis."},{"key":"10.1016\/j.bcp.2024.116555_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114023","article-title":"Role of m6A modification in dysregulation of Wnt\/\u03b2-catenin pathway in cancer","volume":"157","author":"Tabnak","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2024.116555_b0135","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","article-title":"Recognition of RNA N 6 -methyladenosine by IGF2BP proteins enhances mRNA stability and translation","volume":"20","author":"Huang","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bcp.2024.116555_b0140","doi-asserted-by":"crossref","DOI":"10.1097\/CAD.0000000000001591","article-title":"m6A reader IGF2BP1 reduces the sensitivity of nasopharyngeal carcinoma cells to Taxol by upregulation of AKT2","author":"Zhao","year":"2024","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.bcp.2024.116555_b0145","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1505","article-title":"FTO up-regulation induced by MYC suppresses tumour progression in Epstein-Barr virus-associated gastric cancer","volume":"13","author":"Xu","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.bcp.2024.116555_b0150","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10495-023-01893-7","article-title":"N6-methyladenosine reader protein IGF2BP1 suppresses CD8 + T cells-mediated tumor cytotoxicity and apoptosis in colon cancer","volume":"29","author":"Peng","year":"2024","journal-title":"Apoptosis"},{"key":"10.1016\/j.bcp.2024.116555_b0155","doi-asserted-by":"crossref","first-page":"8576","DOI":"10.1093\/nar\/gkaa653","article-title":"The oncofetal RNA-binding protein IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression in cancer","volume":"48","author":"M\u00fcller","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcp.2024.116555_b0160","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1224516","article-title":"IGF2BP family of RNA-binding proteins regulate innate and adaptive immune responses in cancer cells and tumor microenvironment","volume":"14","author":"Elcheva","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2024.116555_b0165","first-page":"G571","article-title":"IMP1\/IGF2BP1 in human colorectal cancer extracellular vesicles","volume":"323","author":"Kuhn","year":"2022","journal-title":"Am. J. Physiol. Liver Physiol."},{"key":"10.1016\/j.bcp.2024.116555_b0170","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/s41388-023-02671-0","article-title":"IGF2BP1 regulates the cargo of extracellular vesicles and promotes neuroblastoma metastasis","volume":"42","author":"Dhamdhere","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2024.116555_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmolb.2021.632219","article-title":"IGF2BP1, a conserved regulator of RNA turnover in cancer","volume":"8","author":"Gla\u00df","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.bcp.2024.116555_b0180","doi-asserted-by":"crossref","first-page":"D218","DOI":"10.1093\/nar\/gkx975","article-title":"ARED-Plus: an updated and expanded database of AU-rich element-containing mRNAs and pre-mRNAs","volume":"46","author":"Bakheet","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcp.2024.116555_b0185","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0968-0004(00)89102-1","article-title":"AU-rich elements: characterization and importance in mRNA degradation","volume":"20","author":"Chen","year":"1995","journal-title":"Trends Biochem. Sci"},{"key":"10.1016\/j.bcp.2024.116555_b0190","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1002\/hep.26997","article-title":"Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) is an important protumorigenic factor in hepatocellular carcinoma","volume":"59","author":"Gutschner","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2024.116555_b0195","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a034728","article-title":"What are 3\u2032 UTRs doing?","volume":"11","author":"Mayr","year":"2019","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.bcp.2024.116555_b0200","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1038\/s41467-020-15403-9","article-title":"An oncopeptide regulates m6A recognition by the m6A reader IGF2BP1 and tumorigenesis","volume":"11","author":"Zhu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2024.116555_b0205","article-title":"LRRC75A-AS1 drives the epithelial-mesenchymal transition in cervical cancer by binding IGF2BP1 and inhibiting SYVN1-mediated NLRP3 ubiquitination","author":"Sui","year":"2024","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bcp.2024.116555_b0210","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12935-023-02895-w","article-title":"A novel feedback regulated loop of circRRM2-IGF2BP1-MYC promotes breast cancer metastasis","volume":"23","author":"Hao","year":"2023","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bcp.2024.116555_b0215","doi-asserted-by":"crossref","first-page":"7074","DOI":"10.1093\/nar\/gki1014","article-title":"The autoregulatory translational control element of poly(A)-binding protein mRNA forms a heteromeric ribonucleoprotein complex","volume":"33","author":"Patel","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcp.2024.116555_b0220","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1261\/rna.1578409","article-title":"IGF2BP1 enhances HCV IRES-mediated translation initiation via the 3\u2032UTR","volume":"15","author":"Weinlich","year":"2009","journal-title":"RNA"},{"key":"10.1016\/j.bcp.2024.116555_b0225","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.tranon.2017.07.008","article-title":"A novel IMP1 inhibitor, BTYNB, targets c-Myc and inhibits melanoma and Ovarian cancer cell proliferation","volume":"10","author":"Mahapatra","year":"2017","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.bcp.2024.116555_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216075","article-title":"IGF2BP1-mediated N6-methyladenosine modification promotes intrahepatic cholangiocarcinoma progression","volume":"557","author":"Xiao","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bcp.2024.116555_b0235","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/15476286.2021.2010983","article-title":"Small molecule inhibitor of Igf2bp1 represses Kras and a pro-oncogenic phenotype in cancer cells","volume":"19","author":"Wallis","year":"2022","journal-title":"RNA Biol."},{"key":"10.1016\/j.bcp.2024.116555_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115940","article-title":"Development of a specific and potent IGF2BP1 inhibitor: a promising therapeutic agent for IGF2BP1-expressing cancers","volume":"263","author":"Singh","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2024.116555_b0245","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied Cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2024.116555_b0250","doi-asserted-by":"crossref","first-page":"236","DOI":"10.18632\/oncotarget.466","article-title":"Targeted therapy for hepatocellular carcinoma: novel agents on the horizon","volume":"3","author":"Cervello","year":"2012","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2024.116555_b0255","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.2174\/0929867325666180105103637","article-title":"Regulation and association with multidrug resistance in hepatocellular carcinoma and colorectal carcinoma","volume":"26","author":"Ceballos","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bcp.2024.116555_b0260","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3109\/07388551.2015.1015957","article-title":"Molecular mechanisms of drug resistance and its reversal in cancer","volume":"36","author":"Kartal-Yandim","year":"2016","journal-title":"Crit. Rev. Biotechnol."},{"key":"10.1016\/j.bcp.2024.116555_b0265","doi-asserted-by":"crossref","unstructured":"M. Alonso-Pe\u00f1a, A. Sanchez-Martin, P. Sanchon-Sanchez, M. Soto-Mu\u00f1iz, R. Espinosa-Escudero, J.J.G. Marin, Pharmacogenetics of hepatocellular carcinoma and cholangiocarcinoma, Cancer Drug Resist. (Alhambra, Calif.) 2 (2019) 680\u2013709, doi: 10.20517\/CDR.2019.006.","DOI":"10.20517\/cdr.2019.006"},{"key":"10.1016\/j.bcp.2024.116555_b0270","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14081606","article-title":"Nanomedicines for overcoming cancer drug resistance","volume":"14","author":"Hu","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bcp.2024.116555_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2019.100645","article-title":"The multi-factorial nature of clinical multidrug resistance in cancer","volume":"46","author":"Assaraf","year":"2019","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bcp.2024.116555_b0280","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/humu.24418","article-title":"The human ATP-binding cassette (ABC) transporter superfamily","volume":"43","author":"Dean","year":"2022","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bcp.2024.116555_b0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.109.002014","article-title":"Xenobiotic, bile acid, and cholesterol transporters: function and regulation","volume":"62","author":"Klaassen","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2024.116555_b0290","unstructured":"The human protein atlas - home page, Hum. Protein Atlas (2024). https:\/\/v15.proteinatlas.org\/."},{"key":"10.1016\/j.bcp.2024.116555_b0295","unstructured":"Expression of ABCB1 in cancer - summary, Hum. Protein Atlas (2024). https:\/\/v15.proteinatlas.org\/ENSG00000085563-ABCB1\/cancer."},{"key":"10.1016\/j.bcp.2024.116555_b0300","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1042\/bse0500161","article-title":"The P-glycoprotein multidrug transporter","volume":"50","author":"Sharom","year":"2011","journal-title":"Essays Biochem."},{"key":"10.1016\/j.bcp.2024.116555_b0305","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3109\/03602532.2014.901348","article-title":"Importance of ABCC1 for cancer therapy and prognosis","volume":"46","author":"Kunick\u00e1","year":"2014","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.bcp.2024.116555_b0310","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1440-1746.2004.03275.x","article-title":"Increased hepatic and renal expressions of multidrug resistance-associated protein 3 in Eisai hyperbilirubinuria rats","volume":"19","author":"Kuroda","year":"2004","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bcp.2024.116555_b0315","unstructured":"Expression of ABCC2 in cancer - Summary, Hum. Protein Atlas (2024). https:\/\/v15.proteinatlas.org\/ENSG00000023839-ABCC2\/cancer."},{"key":"10.1016\/j.bcp.2024.116555_b0320","unstructured":"Expression of ABCC3 in cancer - summary, Hum. Protein Atlas (2024). https:\/\/v15.proteinatlas.org\/ENSG00000108846-ABCC3\/cancer."},{"key":"10.1016\/j.bcp.2024.116555_b0325","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.bcp.2005.03.001","article-title":"Reversal of in vitro cellular MRP1 and MRP2 mediated vincristine resistance by the flavonoid myricetin","volume":"69","author":"van Zanden","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116555_b0330","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/ijc.21013","article-title":"MRP2 (ABCC2) transports taxanes and confers paclitaxel resistance and both processes are stimulated by probenecid","volume":"116","author":"Huisman","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bcp.2024.116555_b0335","doi-asserted-by":"crossref","first-page":"46400","DOI":"10.1074\/jbc.M107041200","article-title":"Characterization of drug transport by the human multidrug resistance protein 3 (ABCC3)","volume":"276","author":"Zelcer","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2024.116555_b0340","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000450911","article-title":"Progress in the molecular characterization of hepatobiliary transporters","volume":"35","author":"Keppler","year":"2017","journal-title":"Dig. Dis."},{"key":"10.1016\/j.bcp.2024.116555_b0345","doi-asserted-by":"crossref","first-page":"e0205175","DOI":"10.1371\/journal.pone.0205175","article-title":"Discovery of novel multidrug resistance protein 4 (MRP4) inhibitors as active agents reducing resistance to anticancer drug 6-Mercaptopurine (6-MP) by structure and ligand-based virtual screening","volume":"13","author":"Chen","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2024.116555_b0350","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.neo.2021.11.002","article-title":"ABCC5 facilitates the acquired resistance of sorafenib through the inhibition of SLC7A11-induced ferroptosis in hepatocellular carcinoma","volume":"23","author":"Huang","year":"2021","journal-title":"Neoplasia"},{"key":"10.1016\/j.bcp.2024.116555_b0355","first-page":"52","article-title":"ABC transporters as cancer drivers: potential functions in cancer development","volume":"2019","author":"Domenichini","year":"1863","journal-title":"Biochim. Biophys. Acta - Gen. Subj."},{"key":"10.1016\/j.bcp.2024.116555_b0360","first-page":"53","article-title":"Human ABC transporter ABCG2\/BCRP expression in chemoresistance: basic and clinical perspectives for molecular cancer therapeutics","volume":"7","author":"Noguchi","year":"2014","journal-title":"Pharmgenomics. Pers. Med."},{"key":"10.1016\/j.bcp.2024.116555_b0365","unstructured":"Expression of ABCG2 in cancer - summary, Hum. Protein Atlas (2024). https:\/\/v15.proteinatlas.org\/ENSG00000118777-ABCG2\/cancer."},{"key":"10.1016\/j.bcp.2024.116555_b0370","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15082365","article-title":"Clinical significance of ABCG2\/BCRP quantified by fluorescent nanoparticles in breast cancer patients undergoing neoadjuvant chemotherapy","volume":"15","author":"Tada","year":"2023","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.bcp.2024.116555_b0375","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21145027","article-title":"ABCG2 protein levels and association to response to first-line irinotecan-based therapy for patients with metastatic colorectal cancer","volume":"21","author":"Palshof","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2024.116555_b0380","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1208\/s12248-014-9668-6","article-title":"Role of the breast cancer resistance protein (BCRP\/ABCG2) in drug transport\u2013an update","volume":"17","author":"Mao","year":"2015","journal-title":"AAPS J."},{"key":"10.1016\/j.bcp.2024.116555_b0385","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1182\/blood-2004-04-1398","article-title":"Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)\/ABCG2 drug pump","volume":"104","author":"Burger","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2024.116555_b0390","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/nar\/gkl1148","article-title":"CRD-BP shields c-myc and MDR-1 RNA from endonucleolytic attack by a mammalian endoribonuclease","volume":"35","author":"Sparanese","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcp.2024.116555_b0395","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1002\/ijc.26190","article-title":"Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of multidrug resistance 1","volume":"130","author":"Boyerinas","year":"2012","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2024.116555_b0400","article-title":"Insulin growth factor 2 mRNA binding protein 1 (IGF2BP1) regulates translation of the multidrug resistance protein 2 (MRP2) by binding to its 5 \u2032 \u00ad untranslated region (5 \u2032 UTR)","volume":"25","author":"Vore","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.bcp.2024.116555_b0405","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1096\/fba.2021-00069","article-title":"Inhibition of insulin-like growth factor 2 mRNA-binding protein 1 sensitizes colorectal cancer cells to chemotherapeutics","volume":"4","author":"Betson","year":"2022","journal-title":"FASEB BioAdv."},{"key":"10.1016\/j.bcp.2024.116555_b0410","first-page":"816","article-title":"Circular RNA circ_0005667 promotes cisplatin resistance of endometrial carcinoma cells by regulating IGF2BP1 through miR-145-5p, Anticancer","volume":"34","author":"Sun","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.bcp.2024.116555_b0415","doi-asserted-by":"crossref","first-page":"20730","DOI":"10.1038\/s41598-023-47956-2","article-title":"A1BG-AS1 promotes adriamycin resistance of breast cancer by recruiting IGF2BP2 to upregulate ABCB1 in an m6A-dependent manner","volume":"13","author":"Wang","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2024.116555_b0420","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1038\/sj.onc.1201110","article-title":"Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein","volume":"14","author":"M\u00fceller-Pillasch","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2024.116555_b0425","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semcancer.2014.07.006","article-title":"The role of the oncofetal IGF2 mRNA-binding protein 3 (IGF2BP3) in cancer","volume":"29","author":"Lederer","year":"2014","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bcp.2024.116555_b0430","doi-asserted-by":"crossref","first-page":"12569","DOI":"10.1074\/jbc.C112.442319","article-title":"IMP3 protein promotes chemoresistance in breast cancer cells by regulating breast cancer resistance protein (ABCG2) expression","volume":"288","author":"Samanta","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2024.116555_b0435","doi-asserted-by":"crossref","first-page":"25149","DOI":"10.18632\/oncotarget.4438","article-title":"An isocorydine derivative (d-ICD) inhibits drug resistance by downregulating IGF2BP3 expression in hepatocellular carcinoma","volume":"6","author":"Li","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2024.116555_b0440","first-page":"1428","article-title":"Binding of RNA m6A by IGF2BP3 triggers chemoresistance of HCT8 cells via upregulation of ABCB1","volume":"11","author":"Yang","year":"2021","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.bcp.2024.116555_b0445","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/cbin.10819","article-title":"Restoration of microRNA-708 sensitizes ovarian cancer cells to cisplatin via IGF2BP1\/Akt pathway","volume":"41","author":"Qin","year":"2017","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.bcp.2024.116555_b0450","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2022.33.e75","article-title":"SP1-induced lncRNA MCF2L-AS1 promotes cisplatin resistance in ovarian cancer by regulating IGF2BP1\/IGF2\/MEK\/ERK axis","volume":"33","author":"Zhu","year":"2022","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.bcp.2024.116555_b0455","article-title":"BIRC5 facilitates cisplatin-chemoresistance in a m6 A-dependent manner in ovarian cancer","volume":"13","author":"Fan","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.bcp.2024.116555_b0460","doi-asserted-by":"crossref","first-page":"11366","DOI":"10.1111\/jcmm.15738","article-title":"METTL3 potentiates resistance to cisplatin through m6 A modification of TFAP2C in seminoma","volume":"24","author":"Wei","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.bcp.2024.116555_b0465","doi-asserted-by":"crossref","unstructured":"Q. Wang, C. Chen, X. Xu, C. Shu, C. Cao, Z. Wang, Y. Fu, L. Xu, K. Xu, J. Xu, A. Xia, B. Wang, G. Xu, X. Zou, R. Su, W. Kang, Y. Xue, R. Mo, B. Sun, S. Wang, APAF1-binding long noncoding RNA promotes tumor growth and multidrug resistance in gastric cancer by blocking apoptosome assembly, Adv. Sci. (Weinheim, Baden-Wurttemberg, Ger. 9 (2022), doi: 10.1002\/ADVS.202201889.","DOI":"10.1002\/advs.202201889"},{"key":"10.1016\/j.bcp.2024.116555_b0470","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3892\/ijo.2023.5567","article-title":"Mechanism of multidrug resistance to chemotherapy mediated by P-glycoprotein (Review)","volume":"63","author":"Tian","year":"2023","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bcp.2024.116555_b0475","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1124\/mol.107.037937","article-title":"Down-regulation of Pregnane X receptor contributes to cell growth inhibition and apoptosis by anticancer agents in endometrial cancer cells","volume":"72","author":"Masuyama","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116555_b0480","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1152\/physrev.00037.2005","article-title":"Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system","volume":"86","author":"Sarkadi","year":"2006","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bcp.2024.116555_b0485","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-022-05502-4","article-title":"AKAP8L enhances the stemness and chemoresistance of gastric cancer cells by stabilizing SCD1 mRNA","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2024.116555_b0490","article-title":"PRMT3-mediated arginine methylation of IGF2BP1 promotes oxaliplatin resistance in liver cancer","volume":"14","author":"Shi","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2024.116555_b0495","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/nature04839","article-title":"CRD-BP mediates stabilization of \u03b2TrCP1 and c-myc mRNA in response to \u03b2-catenin signalling","volume":"441","author":"Noubissi","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2024.116555_b0500","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.tiv.2008.09.001","article-title":"Effect of ABCG2 on cytotoxicity of platinum drugs: interference of EGFP","volume":"22","author":"Ceckova","year":"2008","journal-title":"Toxicol. Vitr."},{"key":"10.1016\/j.bcp.2024.116555_b0505","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1021\/acs.jafc.0c00107","article-title":"\u03b2-Sitosterol reverses multidrug resistance via BCRP suppression by inhibiting the p53\u2013MDM2 interaction in colorectal cancer","volume":"68","author":"Wang","year":"2020","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bcp.2024.116555_b0510","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1038\/s41375-019-0656-9","article-title":"RNA-binding protein IGF2BP1 maintains leukemia stem cell properties by regulating HOXB4, MYB, and ALDH1A1","volume":"34","author":"Elcheva","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2024.116555_b0515","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.608816","article-title":"Inhibition of the mRNA-binding protein IGF2BP1 suppresses proliferation and sensitizes neuroblastoma cells to chemotherapeutic agents","volume":"11","author":"Biegel","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bcp.2024.116555_b0520","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-022-03549-7","article-title":"IGF2BP1-regulated expression of ERR\u03b1 is involved in metabolic reprogramming of chemotherapy resistant osteosarcoma cells","volume":"20","author":"He","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bcp.2024.116555_b0525","article-title":"Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) is a prognostic biomarker and associated with chemotherapy responsiveness in colorectal cancer","volume":"22","author":"Chen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2024.116555_b0530","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.947363","article-title":"IGF2BP1, a new target to overcome drug resistance in melanoma?","volume":"13","author":"Xi","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116555_b0535","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1755-148X.2011.00921.x","article-title":"Inhibition of coding region determinant binding protein sensitizes melanoma cells to chemotherapeutic agents","volume":"25","author":"Craig","year":"2012","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.bcp.2024.116555_b0540","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/mc.22786","article-title":"Targeting insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) in metastatic melanoma to increase efficacy of BRAFV600E inhibitors","volume":"57","author":"Kim","year":"2018","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.bcp.2024.116555_b0545","doi-asserted-by":"crossref","DOI":"10.1186\/s13062-022-00347-5","article-title":"N6-methyladenosine-mediated SH3BP5-AS1 upregulation promotes GEM chemoresistance in pancreatic cancer by activating the Wnt signaling pathway","volume":"17","author":"Lin","year":"2022","journal-title":"Biol. Direct"},{"key":"10.1016\/j.bcp.2024.116555_b0550","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-022-00974-5","article-title":"RRP9 promotes gemcitabine resistance in pancreatic cancer via activating AKT signaling pathway","volume":"20","author":"Zhang","year":"2022","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.bcp.2024.116555_b0555","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-023-02810-1","article-title":"RNA binding protein IGF2BP1 synergizes with ETV6-RUNX1 to drive oncogenic signaling in B-cell Acute Lymphoblastic Leukemia","volume":"42","author":"Sharma","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2024.116555_b0560","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1129","article-title":"LncRNA BC promotes lung adenocarcinoma progression by modulating IMPAD1 alternative splicing","volume":"13","author":"Chen","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.bcp.2024.116555_b0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2023.117783","article-title":"Exosome-shuttled FTO from BM-MSCs contributes to cancer malignancy and chemoresistance in acute myeloid leukemia by inducing m6A-demethylation: a nano-based investigation","volume":"244","author":"Kou","year":"2024","journal-title":"Environ. Res."},{"key":"10.1016\/j.bcp.2024.116555_b0570","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/pros.24632","article-title":"Berbamine targets cancer stem cells and reverses cabazitaxel resistance via inhibiting IGF2BP1 and p-STAT3 in prostate cancer","volume":"84","author":"Wang","year":"2024","journal-title":"Prostate"},{"key":"10.1016\/j.bcp.2024.116555_b0575","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1158\/0008-5472.CAN-21-1323","article-title":"JNK signaling promotes bladder cancer immune escape by regulating METTL3-mediated m6A modification of PD-L1 mRNA","volume":"82","author":"Ni","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2024.116555_b0580","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1021\/acscentsci.2c00107","article-title":"Allosteric regulation of IGF2BP1 as a novel strategy for the activation of tumor immune microenvironment","volume":"8","author":"Liu","year":"2022","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.bcp.2024.116555_b0585","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s10616-023-00594-y","article-title":"The m6A reader IGF2BP1 manipulates BUB1B expression to affect malignant behaviors, stem cell properties, and immune resistance of non-small-cell lung cancer stem cells","volume":"75","author":"Hu","year":"2023","journal-title":"Cytotechnology"},{"key":"10.1016\/j.bcp.2024.116555_b0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115955","article-title":"FGF19\/FGFR4 signaling contributes to hepatocellular carcinoma survival and immune escape by regulating IGF2BP1-mediated expression of PD-L1","volume":"170","author":"Guo","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2024.116555_b0595","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.21037\/tcr-22-881","article-title":"Construction and validation of prognostic prediction established on N6-methyladenosine related genes in cervical squamous cell carcinoma","volume":"11","author":"Chen","year":"2022","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.bcp.2024.116555_b0600","article-title":"A Novel M6A-related genes signature can impact the immune status and predict the prognosis and drug sensitivity of lung adenocarcinoma","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2024.116555_b0605","doi-asserted-by":"crossref","first-page":"7543","DOI":"10.1038\/s41598-024-57910-5","article-title":"Identification of molecular subtypes and a prognostic signature based on m6A\/m5C\/m1A-related genes in lung adenocarcinoma","volume":"14","author":"Zhang","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2024.116555_b0610","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.1547","article-title":"Clinicopathological and immunological characterization of RNA m6 A methylation regulators in ovarian cancer","volume":"9","author":"Wang","year":"2021","journal-title":"Mol. Genet. Genomic Med."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224005550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224005550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T03:02:41Z","timestamp":1732849361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295224005550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":122,"alternative-id":["S0006295224005550"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116555","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of the RNA binding protein IGF2BP1 in cancer multidrug resistance","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116555","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116555"}}